Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases

Chemical Research in Toxicology

Volumn 28, Issue 7, 2015, Pages 1359-1390

  Korobkova, Ekaterina A ^a  

^a JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CHALCONE DERIVATIVE; CYTOCHROME P450; FLAVONOID; LIGNAN; POLYPHENOL DERIVATIVE; PREGNANE X RECEPTOR; STILBENE DERIVATIVE; POLYPHENOL; STEROID RECEPTOR;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FOOD; GENE EXPRESSION REGULATION; HUMAN; NEOPLASM; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; PATHOLOGY;

CARDIOVASCULAR DISEASES; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS; HUMANS; NEOPLASMS; POLYPHENOLS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 84937786508     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.5b00121     Document Type: Review

References (226)

1. Imig, J. D., Simpkins, A. N., Renic, M., and Harder, D. R. (2011) Cytochrome P450 eicosanoids and cerebral vascular function Expert Rev. Mol. Med. 13, e7
2. Tian, Z., Cheng, Q., Yoshimoto, F. K., Lei, L., Lamb, D. C., and Guengerich, F. P. (2013) Cytochrome P450 107U1 is required for sporulation and antibiotic production in Streptomyces coelicolor Arch. Biochem. Biophys. 530, 101-107
3. Guengerich, F. P. (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem. Res. Toxicol. 14, 611-650
4. De Matteis, F., Ballou, D. P., Coon, M. J., Estabrook, R. W., and Haines, D. C. (2012) Peroxidase-like activity of uncoupled cytochrome P450: studies with bilirubin and toxicological implications of uncoupling Biochem. Pharmacol. 84, 374-382
5. Boerma, J. S., Vermeulen, N. P., and Commandeur, J. N. (2014) One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2′-(glutathion-S-yl)-deschloro-diclofenac Chem.-Biol. Interact. 207, 32-40
6. Shahabi, P., Siest, G., Meyer, U. A., and Visvikis-Siest, S. (2014) Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders Pharmacol. Ther. 144, 134-161
7. Barbara, J. E., Kazmi, F., Parkinson, A., and Buckley, D. B. (2013) Metabolism-dependent inhibition of CYP3A4 by lapatinib: evidence for formation of a metabolic intermediate complex with a nitroso/oxime metabolite formed via a nitrone intermediate Drug Metab. Dispos. 41, 1012-1022
8. Wójcikowski, J., Boksa, J., and Daniel, W. A. (2010) Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver - A comparison with other phenothiazines Biochem. Pharmacol. 80, 1252-1259
9. Lai, W. and Shaik, S. (2011) Can ferric-superoxide act as a potential oxidant in P450(cam)? QM/MM investigation of hydroxylation, epoxidation, and sulfoxidation J. Am. Chem. Soc. 133, 5444-5452
10. Zamperini, C., Dreassi, E., Vignaroli, G., Radi, M., Dragoni, S., Schenone, S., Musumeci, F., Valoti, M., Antiochia, R., and Botta, M. (2014) CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction Drug Metab. Pharmacokinet. 29, 433-440
11. Salcido-Neyoy, M. E., Sierra-Santoyo, A., Beltrán-Ramírez, O., Macías-Pérez, J. R., and Villa-Treviño, S. (2009) Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer World J. Gastroenterol. 15, 2345-2350
12. Ji, L. and Schüürmann, G. (2012) Computational evidence for α-nitrosamino radical as initial metabolite for both the P450 dealkylation and denitrosation of carcinogenic nitrosamines J. Phys. Chem. B 116, 903-912
13. Guengerich, F. P. and Munro, A. W. (2013) Unusual cytochrome p450 enzymes and reactions J. Biol. Chem. 288, 17065-17073
14. Prasad, B., Mah, D. J., Lewis, A. R., and Plettner, E. (2013) Water oxidation by a cytochrome p450: mechanism and function of the reaction PLoS One 8, e61897
15. Koch, C., Tria, G., Fielding, A. J., Brodhun, F., Valerius, O., Feussner, K., Braus, G. H., Svergun, D. I., Bennati, M., and Feussner, I. (2013) A structural model of PpoA derived from SAXS-analysis-implications for substrate conversion Biochim. Biophys. Acta 1831, 1449-1457
16. Toporkova, Y. Y., Ermilova, V. S., Gorina, S. S., Mukhtarova, L. S., Osipova, E. V., Gogolev, Y. V., and Grechkin, A. N. (2013) Structure-function relationship in the CYP74 family: conversion of divinyl ether synthases into allene oxide synthases by site-directed mutagenesis FEBS Lett. 587, 2552-2558
17. Gao, L., Tu, Y., Wegman, P., Wingren, S., and Eriksson, L. A. (2011) A mechanistic hypothesis for the cytochrome P450-catalyzed cis-trans isomerization of 4-hydroxytamoxifen: an unusual redox reaction J. Chem. Inf. Model. 51, 2293-2301
18. Singh, R., Bordeaux, M., and Fasan, R. (2014) P450-catalyzed intramolecular sp3 C-H amination with arylsulfonyl azide substrates ACS Catal. 4, 546-552
19. Barry, S. M., Kers, J. A., Johnson, E. G., Song, L., Aston, P. R., Patel, B., Krasnoff, S. B., Crane, B. R., Gibson, D. M., Loria, R., and Challis, G. L. (2012) Cytochrome P450-catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis Nat. Chem. Biol. 8, 814-816
20. Guengerich, F. P. (2003) Cytochromes P450, drugs, and diseases Mol. Interventions 3, 194-204
21. Zanger, U. M. and Schwab, M. (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation Pharmacol. Ther. 138, 103-141
22. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer J. Biol. Chem. 279, 23847-23850
23. Uno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., and Nebert, D. W. (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation Mol. Pharmacol. 65, 1225-1237
24. Uno, S., Dalton, T. P., Dragin, N., Curran, C. P., Derkenne, S., Miller, M. L., Shertzer, H. G., Gonzalez, F. J., and Nebert, D. W. (2006) Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate Mol. Pharmacol. 69, 1103-1114
25. Iqbal, J., Sun, L., Cao, J., Yuen, T., Lu, P., Bab, I., Leu, N. A., Srinivasan, S., Wagage, S., Hunter, C. A., Nebert, D. W., Zaidi, M., and Avadhani, N. G. (2013) Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes Proc. Natl. Acad. Sci. U.S.A. 110, 11115-11120
26. Hussain, T., Al-Attas, O. S., Al-Daghri, N. M., Mohammed, A. A., De Rosas, E., Ibrahim, S., Vinodson, B., Ansari, M. G., and El-Din, K. I. (2014) Induction of CYP1A1, CYP1A2, CYP1B1, increased oxidative stress and inflammation in the lung and liver tissues of rats exposed to incense smoke Mol. Cell. Biochem. 391, 127-136
27. Androutsopoulos, V. P., Spyrou, I., Ploumidis, A., Papalampros, A. E., Kyriakakis, M., Delakas, D., Spandidos, D. A., and Tsatsakis, A. M. (2013) Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors PLoS One 8, e82487
28. Kang, J. S., Wanibuchi, H., Morimura, K., Gonzalez, F. J., and Fukushima, S. (2007) Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo Cancer Res. 67, 11141-11146
29. Chowdhury, G., Calcutt, M. W., Nagy, L. D., and Guengerich, F. P. (2012) Oxidation of methyl and ethyl nitrosamines by cytochrome P450 2E1 and 2B1 Biochemistry 51, 9995-10007
30. Wienkers, L. C. and Heath, T. G. (2005) Predicting in vivo drug interactions from in vitro drug discovery data Nat. Rev. Drug Discovery 4, 825-833
31. Keshava, C., McCanlies, E. C., and Weston, A. (2004) CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a HuGE review Am. J. Epidemiol. 160, 825-841
32. Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E., and Zeldin, D. C. (2006) The human intestinal cytochrome P450 "pie" Drug Metab. Dispos. 34, 880-886
33. Ding, X. and Kaminsky, L. S. (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 43, 149-173
34. Pavek, P. and Dvorak, Z. (2008) Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues Curr. Drug Metab. 129-143
35. Haduch, A., Bromek, E., Sadakierska-Chudy, A., Wójcikowski, J., and Daniel, W. A. (2013) The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study Pharmacol. Res. 67, 53-59
36. Zhou, K., Khokhar, J. Y., Zhao, B., and Tyndale, R. F. (2013) First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo Biochem. Pharmacol. 85, 1848-1855
37. Curnow, K. M., Tusie-Luna, M. T., Pascoe, L., Natarajan, R., Gu, J. L., Nadler, J. L., and White, P. C. (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex Mol. Endocrinol. 5, 1513-1522
38. Wilson, T. E., Mouw, A. R., Weaver, C. A., Milbrandt, J., and Parker, K. L. (1993) The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase Mol. Cell. Biol. 13, 861-868
39. Bolbrinker, J., Seeberg, S., Schostak, M., Kempkensteffen, C., Baelde, H., de Heer, E., and Kreutz, R. (2012) CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5∗1 allele Drug Metab. Dispos. 40, 639-641
40. Frömel, T., Kohlstedt, K., Popp, R., Yin, X., Awwad, K., Barbosa-Sicard, E., Thomas, A. C., Lieberz, R., Mayr, M., and Fleming, I. (2013) Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques Basic Res. Cardiol. 108, 319
41. Kartha, J. S. and Yost, G. S. (2008) Mechanism-based inactivation of lung-selective cytochrome P450 CYP2F enzymes Drug Metab. Dispos. 36, 155-162
42. Weems, J. M. and Yost, G. S. (2010) 3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively Chem. Res. Toxicol. 23, 696-704
43. Ahn, T. and Yun, C. H. (2010) Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes Curr. Drug Metab. 830-838
44. 2-terminal chimeric signals involves an unusual TOM20/TOM22 bypass mechanism J. Biol. Chem. 284, 17352-17363
45. Neve, E. P., Eliasson, E., Pronzato, M. A., Albano, E., Marinari, U., and Ingelman-Sundberg, M. (1996) Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus Arch. Biochem. Biophys. 333, 459-465
46. Avadhani, N. G., Sangar, M. C., Bansal, S., and Bajpai, P. (2011) Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals FEBS J. 278, 4218-4229
47. Pandey, K. B. and Rizvi, S. I. (2009) Plant polyphenols as dietary antioxidants in human health and disease Oxid. Med. Cell. Longevity 2, 270-278
48. Lagoa, R., Graziani, I., Lopez-Sanchez, C., Garcia-Martinez, V., and Gutierrez-Merino, C. (2011) Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria Biochim. Biophys. Acta 1807, 1562-1572
49. Salvi, M., Brunati, A. M., Clari, G., and Toninello, A. (2002) Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition pore Biochim. Biophys. Acta 1556, 187-196
50. Ohgami, K., Ilieva, I., Shiratori, K., Koyama, Y., Jin, X. H., Yoshida, K., Kase, S., Kitaichi, N., Suzuki, Y., Tanaka, T., and Ohno, S. (2005) Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis Invest. Ophthalmol. Vis. Sci. 46, 275-281
51. Naruszewicz, M., Laniewska, I., Millo, B., and Dłuzniewski, M. (2007) Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI) Atherosclerosis 194, e179-e184
52. Qin, B. and Anderson, R. A. (2012) An extract of chokeberry attenuates weight gain and modulates insulin, adipogenic and inflammatory signalling pathways in epididymal adipose tissue of rats fed a fructose-rich diet Br. J. Nutr. 108, 581-587
53. Howatson, G., McHugh, M. P., Hill, J. A., Brouner, J., Jewell, A. P., van Someren, K. A., Shave, R. E., and Howatson, S. A. (2010) Influence of tart cherry juice on indices of recovery following marathon running Scand. J. Med. Sci. Sports 20, 843-852
54. Butt, M. S., Imran, A., Sharif, M. K., Ahmad, R. S., Xiao, H., Imran, M., and Rsool, H. A. (2014) Black tea polyphenols: a mechanistic treatise Crit. Rev. Food Sci. Nutr. 54, 1002-1011
55. Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H., Shastri, A., Su, R., Bapat, P., Kwun, I., and Shen, C. L. (2014) Novel insights of dietary polyphenols and obesity J. Nutr. Biochem. 25, 1-18
56. Bhatti, S. K., O'Keefe, J. H., and Lavie, C. J. (2013) Coffee and tea: perks for health and longevity? Curr. Opin. Clin. Nutr. Metab. Care 16, 688-697
57. Khurana, S., Venkataraman, K., Hollingsworth, A., Piche, M., and Tai, T. C. (2013) Polyphenols: benefits to the cardiovascular system in health and in aging Nutrients 5, 3779-3827
58. Lambert, J. D. and Elias, R. J. (2010) The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention Arch. Biochem. Biophys. 501, 65-72
59. Basu, A., Nguyen, A., Betts, N. M., and Lyons, T. J. (2014) Strawberry as a functional food: an evidence-based review Crit. Rev. Food Sci. Nutr. 54, 790-806
60. Xiao, J., Ni, X., Kai, G., and Chen, X. (2013) A review on structure-activity relationship of dietary polyphenols inhibiting α-amylase Crit. Rev. Food Sci. Nutr. 53, 497-506
61. Xiao, J., Kai, G., Yamamoto, K., and Chen, X. (2013) Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect Crit. Rev. Food Sci. Nutr. 53, 818-836
62. Xiao, J. B., Huo, J. L., Yang, F., and Chen, X. Q. (2011) Noncovalent interaction of dietary polyphenols with bovine hemoglobin in vitro: molecular structure/property-affinity relationship aspects J. Agric. Food Chem. 59, 8484-8490
63. Xiao, J. and Kai, G. (2012) A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship Crit. Rev. Food Sci. Nutr. 52, 85-101
64. Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., Storelli, C., Martines, G., De Caterina, R., and Carluccio, M. A. (2012) Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer Arch. Biochem. Biophys. 527, 81-89
65. Scoditti, E., Nestola, A., Massaro, M., Calabriso, N., Storelli, C., De Caterina, R., and Carluccio, M. A. (2014) Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition Atherosclerosis 232, 17-24
66. Bai, H. W. and Zhu, B. T. (2008) Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids J. Lipid Res. 49, 2557-2570
67. Henning, S. M., Wang, P., Said, J., Magyar, C., Castor, B., Doan, N., Tosity, C., Moro, A., Gao, K., Li, L., and Heber, D. (2012) Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis J. Nutr. Biochem. 23, 1537-1542
68. Li, Y. and Tollefsbol, T. O. (2010) Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components Curr. Med. Chem. 17, 2141-2151
69. Senthilvel, P., Lavanya, P., Kumar, K. M., Swetha, R., Anitha, P., Bag, S., Sarveswari, S., Vijayakumar, V., Ramaiah, S., and Anbarasu, A. (2013) Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly Bioinformation 9, 889-895
70. Kiat, T. S., Pippen, R., Yusof, R., Ibrahim, H., Khalid, N., and Rahman, N. A. (2006) Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease Bioorg. Med. Chem. Lett. 16, 3337-3340
71. Mukhametov, A., Newhouse, E. I., Aziz, N. A., Saito, J. A., and Alam, M. (2014) Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition J. Mol. Graphic Modell. 52, 103-113
72. Cao, H., Pan, X., Li, C., Zhou, C., Deng, F., and Li, T. (2003) Density functional theory calculations for resveratrol Bioorg. Med. Chem. Lett. 13, 1869-1871
73. Szewczuk, L. M., Lee, S. H., Blair, I. A., and Penning, T. M. (2005) Viniferin formation by COX-1: evidence for radical intermediates during co-oxidation of resveratrol J. Nat. Prod. 68, 36-42
74. 2, semiquinones, and quinones Free Radical Biol. Med. 51, 2319-2327
75. Jacobs, H., Moalin, M., Bast, A., van der Vijgh, W. J., and Haenen, G. R. (2010) An essential difference between the flavonoids monoHER and quercetin in their interplay with the endogenous antioxidant network PLoS One 5, e13880
76. Galati, G., Moridani, M. Y., Chan, T. S., and O'Brien, P. J. (2001) Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation Free Radical Biol. Med. 30, 370-382
77. Sakihama, Y., Cohen, M. F., Grace, S. C., and Yamasaki, H. (2002) Plant phenolic antioxidant and prooxidant activities: phenolics-induced oxidative damage mediated by metals in plants Toxicology 177, 67-80
78. Prigent, S. V. E., Voragen, A. G. J., Visser, A. J. W. G., van Koningsveld, G. A., and Gruppen, H. (2007) Covalent interactions between proteins and oxidation products of caffeoylquinic acid (chlorogenic acid) J. Sci. Food Agric. 87, 2502-2510
79. Awad, H. M., Boersma, M. G., Boeren, S., van der Woude, H., van Zanden, J., van Bladeren, P. J., Vervoort, J., and Rietjens, I. M. (2002) Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system FEBS Lett. 520, 30-34
80. Brudzynski, K., Sjaarda, C., and Maldonado-Alvarez, L. (2013) A new look on protein-polyphenol complexation during honey storage: is this a random or organized event with the help of dirigent-like proteins? PLoS One 8, e72897
81. Prodpran, T., Benjakul, S., and Phatcharat, S. (2012) Effect of phenolic compounds on protein cross-linking and properties of film from fish myofibrillar protein Int. J. Biol. Macromol. 51, 774-782
82. Jongberg, S., Tørngren, M. A., Gunvig, A., Skibsted, L. H., and Lund, M. N. (2012) Effect of green tea or rosemary extract on protein oxidation in Bologna type sausages prepared from oxidatively stressed pork Meat Sci. 93, 538-546
83. Kanakis, C. D., Hasni, I., Bourassa, P., Hamdani, S., Tarantilis, P. A., and Tajmir-Riahi, H. A. (2011) Milk β-lactoglobulin complexes with tea polyphenols Food Chem. 127, 1046-1055
84. Ozdal, T., Capanoglu, E., and Altay, F. (2013) A review on protein-phenolic interactions and associated changes Food Res. Int. 51, 954-970
85. Aspromonte, N., Monitillo, F., Puzzovivo, A., Valle, R., Caldarola, P., and Iacoviello, M. (2014) Modulation of cardiac cytochrome P450 in patients with heart failure Expert. Opin. Drug Metab. Toxicol. 10, 327-339
86. Chang, Q., Berdyshev, E., Bogaard, J., White, J. J., Chen, S., Shah, R., Mu, W., Grantner, R., Bettis, S., and Grassi, M. A. (2014) Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors J. Biol. Chem. 289, 8337-8352
87. Badal, S. and Delgoda, R. (2014) Role of the modulation of CYP1A1 expression and activity in chemoprevention J. Appl. Toxicol. 34, 743-753
88. Bains, R. K. (2013) African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases Evol. Med. Public Health 2013, 118-134
89. (2004) USDA Database for the Proanthocyanidin. Content of Selected Foods, Nutrient Data Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, U.S. Department of Agriculture, Washington, DC
90. Carpenter, J. L., Caruso, F. L., Tata, A., Vorsa, N., and Neto, C. C. (2014) Variation in proanthocyanidin content and composition among commonly grown North American cranberry cultivars (Vaccinium macrocarpon) J. Sci. Food Agric. 94, 2738-2745
91. Quijada-Morín, N., Williams, P., Rivas-Gonzalo, J. C., Doco, T., and Escribano-Bailón, M. T. (2014) Polyphenolic, polysaccharide and oligosaccharide composition of Tempranillo red wines and their relationship with the perceived astringency Food Chem. 154, 44-51
92. Pascoal, A. C., Ehrenfried, C. A., Lopez, B. G., de Araujo, T. M., Pascoal, V. D., Gilioli, R., Anhê, G. F., Ruiz, A. L., Carvalho, J. E., Stefanello, M. E., and Salvador, M. J. (2014) Antiproliferative activity and induction of apoptosis in PC-3 cells by the chalcone cardamonin from Campomanesia adamantium (Myrtaceae) in a bioactivity-guided study Molecules 19, 1843-1855
93. Wesołowska, O., Gąsiorowska, J., Petrus, J., Czarnik-Matusewicz, B., and Michalak, K. (2014) Interaction of prenylated chalcones and flavanones from common hop with phosphatidylcholine model membranes Biochim. Biophys. Acta 1838, 173-184
94. Birari, R. B., Gupta, S., Mohan, C. G., and Bhutani, K. K. (2011) Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies Phytomedicine 18, 795-801
95. Garazd, M. M., Garazd, Ya. L., and Khilya, V. P. (2003) Neoflavones. 1. Natural distribution and spectral and biological properties Chem. Nat. Compd. 39, 54-121
96. Shirota, O., Pathak, V., Sekita, S., Satake, M., Nagashima, Y., Hirayama, Y., Hakamata, Y., and Hayashi, T. (2003) Phenolic constituents from Dalbergia cochinchinensis J. Nat. Prod. 66, 1128-1131
97. Lee, K. H., Yang, M. C., Kim, K. H., Kwon, H. C., Choi, S. U., and Lee, K. R. (2008) A new phenolic amide from the roots of Paris verticillata Molecules 13, 41-45
98. Oliveira, A. L. L., Silva, D. B., Lopes, N. P., Hosana M. Debonsi, H. M., and Yokoya, N. S. (2012) Chemical constituents from red algae Bostrychia radicans (Rhodomelaceae): new amides and phenolic compounds Quim. Nova 35, 2186-2188
99. Fuentealba, C., Figuerola, F., Estévez, A. M., Bastías, J. M., and Muñoz, O. (2014) Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process J. Sci. Food Agric. 94, 1729-1738
100. Liu, H., Zhang, J., Li, X., Qi, Y., Peng, Y., Zhang, B., and Xiao, P. (2012) Chemical analysis of twelve lignans in the fruit of Schisandra sphenanthera by HPLC-PAD-MS Phytomedicine 19, 1234-1241
101. Chen, J., Saggar, J. K., Corey, P., and Thompson, L. U. (2009) Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice J. Nutr. 139, 2061-2066
102. Brooks, J. D. and Thompson, L. U. (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells J. Steroid Biochem. Mol. Biol. 94, 461-467
103. Jin, J. S., Lee, J. H., and Hattori, M. (2013) Ligand binding affinities of arctigenin and its demethylated metabolites to estrogen receptor alpha Molecules 18, 1122-1127
104. Mueller, S. O., Simon, S., Chae, K., Metzler, M., and Korach, K. S. (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells Toxicol. Sci. 80, 14-25
105. Keser, S., Celik, S., and Turkoglu, S. (2013) Total phenolic contents and free-radical scavenging activities of grape (Vitis vinifera L.) and grape products Int. J. Food Sci. Nutr. 64, 210-216
106. Sales, J. M. and Resurreccion, A. V. (2014) Resveratrol in peanuts Crit. Rev. Food Sci. Nutr. 54, 734-770
107. Shimada, T., Tanaka, K., Takenaka, S., Murayama, N., Martin, M. V., Foroozesh, M. K., Yamazaki, H., Guengerich, F. P., and Komori, M. (2010) Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives Chem. Res. Toxicol. 23, 1921-1935
108. Lean, M. E., Noroozi, M., Kelly, I., Burns, J., Talwar, D., Sattar, N., and Crozier, A. (1999) Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA Diabetes 48, 176-181
109. Shimada, T., Tanaka, K., Takenaka, S., Foroozesh, M. K., Murayama, N., Yamazaki, H., Guengerich, F. P., and Komori, M. (2009) Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study Chem. Res. Toxicol. 22, 1325-1333
110. Androutsopoulos, V. P., Papakyriakou, A., Vourloumis, D., and Spandidos, D. A. (2011) Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids Bioorg. Med. Chem. 19, 2842-2849
111. Kimura, Y., Ito, H., Ohnishi, R., and Hatano, T. (2010) Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity Food Chem. Toxicol. 48, 429-435
112. Takemura, H., Itoh, T., Yamamoto, K., Sakakibara, H., and Shimoi, K. (2010) Selective inhibition of methoxyflavonoids on human CYP1B1 activity Bioorg. Med. Chem. 18, 6310-6315
113. Michler, H., Laakmann, G., and Wagner, H. (2011) Development of an LC-MS method for simultaneous quantitation of amentoflavone and biapigenin, the minor and major biflavones from Hypericum perforatum L., in human plasma and its application to real blood Phytochem. Anal. 22, 42-50
114. Meyer, H., Bolarinwa, A., Wolfram, G., and Linseisen, J. (2006) Bioavailability of apigenin from apiin-rich parsley in humans Ann. Nutr. Metab. 50, 167-172
115. Cao, J., Zhang, Y., Chen, W., and Zhao, X. (2010) The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake Br. J. Nutr. 103, 249-255
116. Marks, S. C., Mullen, W., Borges, G., and Crozier, A. (2009) Absorption, metabolism, and excretion of cider dihydrochalcones in healthy humans and subjects with an ileostomy J. Agric. Food Chem. 57, 2009-2015
117. Borges, G., Mullen, W., Mullan, A., Lean, M. E., Roberts, S. A., and Crozier, A. (2010) Bioavailability of multiple components following acute ingestion of a polyphenol-rich juice drink Mol. Nutr. Food Res. 54, S268-S277
118. Stracke, B. A., Rüfer, C. E., Bub, A., Seifert, S., Weibel, F. P., Kunz, C., and Watzl, B. (2010) No effect of the farming system (organic/conventional) on the bioavailability of apple (Malus domestica Bork., cultivar Golden Delicious) polyphenols in healthy men: a comparative study Eur. J. Nutr. 49, 301-310
119. Si, D., Wang, Y., Zhou, Y. H., Guo, Y., Wang, J., Zhou, H., Li, Z. S., and Fawcett, J. P. (2009) Mechanism of CYP2C9 inhibition by flavones and flavonols Drug Metab. Dispos. 37, 629-634
120. Boocock, D. J., Faust, G. E., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., Steward, W. P., and Brenner, D. E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev 16, 1246-1252
121. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., and Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 32, 1377-1382
122. Chun, Y. J., Oh, Y. K., Kim, B. J., Kim, D., Kim, S. S., Choi, H. K., and Kim, M. Y. (2009) Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene Toxicol. Lett. 189, 84-89
123. Mikstacka, R., Rimando, A. M., Dutkiewicz, Z., Stefański, T., and Sobiak, S. (2012) Design, synthesis and evaluation of the inhibitory selectivity of novel trans - resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1 Bioorg. Med. Chem. 20, 5117-5126
124. Karkola, S. and Wähälä, K. (2009) The binding of lignans, flavonoids and coumestrol to CYP450 aromatase: a molecular modelling study Mol. Cell. Endocrinol. 301, 235-244
125. Mo, S. L., Liu, W. F., Chen, Y., Luo, H. B., Sun, L. B., Chen, X. W., Zhou, Z. W., Sneed, K. B., Li, C. G., Du, Y. M., Liang, J., and Zhou, S. F. (2012) Ligand- and protein-based modeling studies of the inhibitors of human cytochrome P450 2D6 and a virtual screening for potential inhibitors from the Chinese herbal medicine, Scutellaria baicalensis (Huangqin, Baikal Skullcap) Comb. Chem. High Throughput Screen. 15, 36-80
126. Yuan, Y., Qiu, X., Nikolić, D., Chen, S. N., Huang, K., Li, G., Pauli, G. F., and van Breemen, R. B. (2014) Inhibition of human cytochrome P450 enzymes by hops (Humulus lupulus) and hop prenylphenols Eur. J. Pharm. Sci. 53, 55-61
127. Im, Y., Kim, Y. W., Song, I. S., Joo, J., Shin, J. H., Wu, Z., Lee, H. S., Park, K. H., and Liu, K. H. (2012) Effect of TSHAC on human cytochrome P450 activity, and transport mediated by P-glycoprotein J. Microbiol. Biotechnol. 22, 1659-1664
128. Lee, S. A., Lee, M. S., Ryu, H. W., Kwak, T. K., Kim, H., Kang, M., Jung, O., Kim, H. J., Park, K. H., and Lee, J. W. (2011) Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib Cancer Biol. Ther. 11, 330-336
129. Liu, J., Taylor, S. F., Dupart, P. S., Arnold, C. L., Sridhar, J., Jiang, Q., Wang, Y., Skripnikova, E. V., Zhao, M., and Foroozesh, M. (2013) Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1 J. Med. Chem. 56, 4082-4092
130. Sridhar, J., Ellis, J., Dupart, P., Liu, J., Stevens, C. L., and Foroozesh, M. (2012) Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2 Drug Metab. Lett. 6, 275-284
131. Hollenberg, P. F., Kent, U. M., and Bumpus, N. N. (2008) Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications Chem. Res. Toxicol. 21, 189-205
132. Williams, P. A., Cosme, J., Ward, A., Angove, H. C., Matak Vinković, D., and Jhoti, H. (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin Nature 424, 464-468
133. Taesotikul, T., Dumrongsakulchai, W., Wattanachai, N., Navinpipat, V., Somanabandhu, A., Tassaneeyakul, W., and Tassaneeyakul, W. (2011) Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition Drug Metab. Pharmacokinet. 26, 154-161
134. Lai, L., Hao, H., Wang, Q., Zheng, C., Zhou, F., Liu, Y., Wang, Y., Yu, G., Kang, A., Peng, Y., Wang, G., and Chen, X. (2009) Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats Drug Metab. Dispos. 37, 2399-2407
135. Song, J. H., Sun, D. X., Chen, B., Ji, D. H., Pu, J., Xu, J., Tian, F. D., and Guo, L. (2011) Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions J. Biosci. (New Delhi, India) 36, 879-885
136. Qin, L., Xue, M., Wang, W., Zhu, R., Wang, S., Sun, J., Zhang, R., and Sun, X. (2010) The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin Int. J. Pharm. 388, 223-230
137. Jeong, H. U., Kong, T. Y., Kwon, S. S., Hong, S. W., Yeon, S. H., Choi, J. H., Lee, J. Y., Cho, Y. Y., and Lee, H. S. (2013) Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes Molecules 18, 10681-10693
138. Jiang, Q. Q., Fan, L. Y., Yang, G. L., Guo, W. H., Hou, W. L., Chen, L. J., and Wei, Y. Q. (2008) Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model BMC Cancer 8, 242
139. Wang, X., Duan, X., Yang, G., Zhang, X., Deng, L., Zheng, H., Deng, C., Wen, J., Wang, N., Peng, C., Zhao, X., Wei, Y., and Chen, L. (2011) Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model PLoS One 6, e18490
140. Joo, J., Lee, D., Wu, Z., Shin, J. H., Lee, H. S., Kwon, B. M., Huh, T. L., Kim, Y. W., Lee, S. J., Kim, T. W., Lee, T., and Liu, K. H. (2013) In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes Biopharm. Drug Dispos. 34, 195-202
141. Messina, A., Puccinelli, E., Gervasi, P. G., and Longo, V. (2013) Expression and inducibility of CYP1A1, 1A2, 1B1 by β-naphthoflavone and CYP2B22, CYP3As by rifampicin in heart regions and coronary arteries of pig Res. Vet. Sci. 94, 77-83
142. Messina, A., Nannelli, A., Fiorio, R., Longo, V., and Gervasi, P. G. (2009) Expression and inducibility of CYP1A1, 1A2, 1B1 by beta-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig Toxicology 260, 47-52
143. Mrozikiewicz, P. M., Bogacz, A., Czerny, B., Karasiewicz, M., Kujawski, R., Mikolajczak, P. L., Seremak-Mrozikiewicz, A., Grzeskowiak, E., and Bobkiewicz-Kozlowska, T. (2010) The influence of a standardized soybean extract (Glycine max) on the expression level of cytochrome P450 genes in vivo Ginekol. Polym. 81, 516-520
144. Abarikwu, S. O., Farombi, E. O., and Pant, A. B. (2012) Kolaviron biflavanoids of Garcinia kola seeds protect atrazine-induced cytotoxicity in primary cultures of rat Leydig cells Int. J. Toxicol. 31, 407-415
145. Miller, W. L. and Bose, H. S. (2011) Early steps in steroidogenesis: intracellular cholesterol trafficking J. Lipid Res. 52, 2111-2135
146. Abarikwu, S. O., Pant, A. B., and Farombi, E. O. (2013) Effects of quercetin on mRNA expression of steroidogenesis genes in primary cultures of Leydig cells treated with atrazine Toxicol. in Vitro 27, 700-707
147. Zhang, B., Xie, W., and Krasowski, M. D. (2008) PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics Pharmacogenomics 9, 1695-1709
148. Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., and Redinbo, M. R. (2001) The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity Science 292, 2329-2333
149. Watkins, R. E., Maglich, J. M., Moore, L. B., Wisley, J. B., Noble, S. M., Davis-Searles, P. R., Lambert, M. H., Kliewer, S. A., and Redinbo, M. R. (2003) 2.1 Å crystal structure of human PXR in complex with St. John's wort compound hyperforin Biochemistry 42, 1430-1438
150. Frank, C., Makkonen, H., Dunlop, T. W., Matilainen, M., Väisänen, S., and Carlberg, C. (2005) Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis J. Mol. Biol. 346, 505-519
151. Satsu, H., Hiura, Y., Mochizuki, K., Hamada, M., and Shimizu, M. (2008) Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals J. Agric. Food Chem. 56, 5366-5373
152. Li, Y., Wang, Q., Yao, X., and Li, Y. (2010) Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways Eur. J. Pharmacol. 640, 46-54
153. Li, Y., Ross-Viola, J. S., Shay, N. F., Moore, D. D., and Ricketts, M. L. (2009) Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner J. Nutr. 139, 898-904
154. Yu, C., Chai, X., Yu, L., Chen, S., and Zeng, S. (2011) Identification of novel pregnane X receptor activators from traditional Chinese medicines J. Ethnopharmacol. 136, 137-143
155. Mooiman, K. D., Maas-Bakker, R. F., Moret, E. E., Beijnen, J. H., Schellens, J. H., and Meijerman, I. (2013) Milk thistle's active components silybin and isosilybin: novel inhibitors of PXR-mediated CYP3A4 induction Drug Metab. Dispos. 41, 1494-1504
156. Dong, H., Lin, W., Wu, J., and Chen, T. (2010) Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells BMC Biochem. 11, 23-31
157. Pondugula, S. R., Dong, H., and Chen, T. (2009) Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression Expert Opin. Drug Metab. Toxicol. 5, 861-873
158. Lin, W., Wu, J., Dong, H., Bouck, D., Zeng, F. Y., and Chen, T. (2008) Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells J. Biol. Chem. 283, 30650-30657
159. Stevens, E. A., Mezrich, J. D., and Bradfield, C. A. (2009) The aryl hydrocarbon receptor: a perspective on potential roles in the immune system Immunology 127, 299-311
160. Wincent, E., Amini, N., Luecke, S., Glatt, H., Bergman, J., Crescenzi, C., Rannug, A., and Rannug, U. (2009) The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans J. Biol. Chem. 284, 2690-2696
161. Petrulis, J. R. and Perdew, G. H. (2002) The role of chaperone proteins in the aryl hydrocarbon receptor core complex Chem.-Biol. Interact. 141, 25-40
162. Soshilov, A. and Denison, M. S. (2011) Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain J. Biol. Chem. 286, 35275-35282
163. Spink, D. C., Wu, S. J., Spink, B. C., Hussain, M. M., Vakharia, D. D., Pentecost, B. T., and Kaminsky, L. S. (2008) Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites Toxicol. Appl. Pharmacol. 226, 213-224
164. Amakura, Y., Tsutsumi, T., Sasaki, K., Nakamura, M., Yoshida, T., and Maitani, T. (2008) Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay Phytochemistry 69, 3117-3130
165. Denison, M. S. and Nagy, S. R. (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43, 309-334
166. Soshilov, A. A. and Denison, M. S. (2014) Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis Mol. Cell. Biol. 34, 1707-1719
167. Ashida, H., Fukuda, I., Yamashita, T., and Kanazawa, K. (2000) Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin FEBS Lett. 476, 213-217
168. Ciolino, H. P. and Yeh, G. C. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol Mol. Pharmacol. 56, 760-767
169. Fukuda, I., Sakane, I., Yabushita, Y., Sawamura, S., Kanazawa, K., and Ashida, H. (2004) Black tea extract suppresses transformation of aryl hydrocarbon receptor induced by dioxin Biofactors 21, 367-369
170. Zhang, T., Jiang, S., He, C., Kimura, Y., Yamashita, Y., and Ashida, H. (2013) Black soybean seed coat polyphenols prevent B(a)P-induced DNA damage through modulating drug-metabolizing enzymes in HepG2 cells and ICR mice Mutat. Res. 752, 34-41
171. Poon, C. H., Wong, T. Y., Wang, Y., Tsuchiya, Y., Nakajima, M., Yokoi, T., and Leung, L. K. (2013) The citrus flavanone naringenin suppresses CYP1B1 transactivation through antagonising xenobiotic-responsive element binding Br. J. Nutr. 109, 1598-1605
172. Zhang, T., Kimura, Y., Jiang, S., Harada, K., Yamashita, Y., and Ashida, H. (2014) Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells Arch. Biochem. Biophys. 557, 36-46
173. Murray, I. A., Flaveny, C. A., DiNatale, B. C., Chairo, C. R., Schroeder, J. C., Kusnadi, A., and Perdew, G. H. (2010) Antagonism of aryl hydrocarbon receptor signaling by 6,2′,4′-trimethoxyflavone J. Pharmacol. Exp. Ther. 332, 135-144
174. Brauze, D. and Rawłuszko, A. A. (2012) The effect of aryl hydrocarbon receptor ligands on the expression of polymerase (DNA directed) kappa (Polκ), polymerase RNA II (DNA directed) polypeptide A (PolR2a), CYP1B1 and CYP1A1 genes in rat liver Environ. Toxicol. Pharmacol. 34, 819-825
175. Wang, C., Xu, C. X., Bu, Y., Bottum, K. M., and Tischkau, S. A. (2014) Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling Carcinogenesis 35, 703-713
176. Callero, M. A., Suárez, G. V., Luzzani, G., Itkin, B., Nguyen, B., and Loaiza-Perez, A. I. (2012) Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment Int. J. Oncol. 41, 125-134
177. Oleaga, C., García, M., Solé, A., Ciudad, C. J., Izquierdo-Pulido, M., and Noé, V. (2012) CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extracst Eur. J. Nutr. 51, 465-476
178. Jalil, A. M. and Ismail, A. (2008) Polyphenols in cocoa and cocoa products: is there a link between antioxidant properties and health? Molecules 13, 2190-2219
179. Li, L., Stanton, J. D., Tolson, A. H., Luo, Y., and Wang, H. (2009) Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways Pharm. Res. 26, 872-882
180. Kamenickova, A., Anzenbacherova, E., Pavek, P., Soshilov, A. A., Denison, M. S., Anzenbacher, P., and Dvorak, Z. (2013) Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T Toxicol. Lett. 218, 253-259
181. Kamenickova, A., Anzenbacherova, E., Pavek, P., Soshilov, A. A., Denison, M. S., Zapletalova, M., Anzenbacher, P., and Dvorak, Z. (2013) Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines Toxicol. Lett. 221, 1-8
182. Amakura, Y., Yoshimura, M., Takaoka, M., Toda, H., Tsutsumi, T., Matsuda, R., Teshima, R., Nakamura, M., Handa, H., and Yoshida, T. (2014) Characterization of natural aryl hydrocarbon receptor agonists from cassia seed and rosemary Molecules 19, 4956-4966
183. Hiura, Y., Satsu, H., Hamada, M., and Shimizu, M. (2014) Analysis of flavonoids regulating the expression of UGT1A1 via xenobiotic receptors in intestinal epithelial cells Biofactors 40, 336-345
184. Mohammadi-Bardbori, A., Bengtsson, J., Rannug, U., Rannug, A., and Wincent, E. (2012) Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR) Chem. Res. Toxicol. 25, 1878-1884
185. Awad, H. M., Boersma, M. G., Boeren, S., van der Woude, H., van Zanden, J., van Bladeren, P. J., Vervoort, J., and Rietjens, I. M. (2002) Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system FEBS Lett. 520, 30-34
186. Cherviakovsky, E. M., Bolibrukh, D. A., Baranovsky, A. V., Vlasova, T. M., Kurchenko, V. P., Gilep, A. A., and Usanov, S. A. (2006) Oxidative modification of quercetin by hemeproteins Biochem. Biophys. Res. Commun. 342, 459-464
187. Ahmad, A., Syed, F. A., Singh, S., and Hadi, S. M. (2005) Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA Toxicol. Lett. 159, 1-12
188. Hadi, S. M., Bhat, S. H., Azmi, A. S., Hanif, S., Shamim, U., and Ullah, M. F. (2007) Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties Semin. Cancer Biol. 17, 370-376
189. Morel, Y. and Barouki, R. (1998) Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1 J. Biol. Chem. 273, 26969-26976
190. Priyadarsini, R. V., Vinothini, G., Murugan, R. S., Manikandan, P., and Nagini, S. (2011) The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors Nutr. Cancer 63, 218-226
191. Priyadarsini, R. V. and Nagini, S. (2012) Quercetin suppresses cytochrome P450 mediated ROS generation and NFκB activation to inhibit the development of 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinomas Free Radical Res. 46, 41-49
192. Vidjaya Letchoumy, P., Chandra Mohan, K. V., Stegeman, J. J., Gelboin, H. V., Hara, Y., and Nagini, S. (2008) Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model Oncol. Res. 17, 75-85
193. Ohno, M., Sakamoto, K. Q., Ishizuka, M., and Fujita, S. (2009) Crude cacao Theobroma cacao extract reduces mutagenicity induced by benzo[a]pyrene through inhibition of CYP1A activity in vitro Phytother. Res. 23, 1134-1139
194. Choi, D. Y., Lee, J. Y., Kim, M. R., Woo, E. R., Kim, Y. G., and Kang, K. W. (2005) Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation J. Biomed. Sci. 12, 949-959
195. Takemura, H., Nagayoshi, H., Matsuda, T., Sakakibara, H., Morita, M., Matsui, A., Ohura, T., and Shimoi, K. (2010) Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells Toxicology 274, 42-48
196. Vinothkumar, R., Vinoth Kumar, R., Sudha, M., Viswanathan, P., Balasubramanian, T., and Nalini, N. (2014) Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by 1,2-dimethylhydrazine in rat colon carcinogenesis Exp. Mol. Pathol. 96, 15-26
197. Verna, L., Whysner, J., and Williams, G. M. (1996) N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation Pharmacol. Ther. 71, 57-81
198. Beltrán-Ramírez, O., Pérez, R. M., Sierra-Santoyo, A., and Villa-Treviño, S. (2012) Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis Toxicol. Pathol. 40, 466-472
199. Arul, D. and Subramanian, P. (2013) Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats Biochem. Biophys. Res. Commun. 434, 203-209
200. González-Sarrías, A., Azorín-Ortuño, M., Yáñez-Gascón, M. J., Tomás-Barberán, F. A., García-Conesa, M. T., and Espín, J. C. (2009) Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1 J. Agric. Food Chem. 57, 5623-5632
201. Zhang, Y., Gaikwad, N. W., Olson, K., Zahid, M., Cavalieri, E. L., and Rogan, E. G. (2007) Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA Metabolism 56, 887-894
202. Bolton, J. L. and Thatcher, G. R. J. (2008) Potential mechanisms of estrogen quinone carcinogenesis Chem. Res. Toxicol. 21, 93-101
203. Belous, A. R., Hachey, D. L., Dawling, S., Roodi, N., and Parl, F. F. (2007) Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation Cancer Res. 67, 812-817
204. Yue, W., Yager, J. D., Wang, J. P., Jupe, E. R., and Santen, R. J. (2013) Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis Steroids 78, 161-170
205. Huang, B., Warner, M., and Gustafsson, J. A. (2014) Estrogen receptors in breast carcinogenesis and endocrine therapy. Mol. Cell. Endocrinol. DOI: 10.1016/j.mce.2014.11.015.
206. Takemura, H., Uchiyama, H., Ohura, T., Sakakibara, H., Kuruto, R., Amagai, T., and Shimoi, K. (2010) A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells J. Steroid Biochem. Mol. Biol. 118, 70-76
207. Smith, S., Sepkovic, D., Bradlow, H. L., and Auborn, K. J. (2008) 3,3′-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells J. Nutr. 138, 2379-2385
208. Huang, Z., Guengerich, F. P., and Kaminsky, L. S. (1998) 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5 Carcinogenesis 19, 867-872
209. Ye, L., Gho, W. M., Chan, F. L., Chen, S., and Leung, L. K. (2009) Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase Int. J. Cancer. 124, 1028-1036
210. Tiong, C. T., Chen, C., Zhang, S. J., Li, J., Soshilov, A., Denison, M. S., Lee, L. S., Tam, V. H., Wong, S. P., Xu, H. E., and Yong, E. L. (2012) A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein Carcinogenesis 33, 1089-1097
211. Choi, S. J., Shin, S. C., and Choi, J. S. (2011) Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin Arch. Pharm. Res. 34, 309-315
212. Choi, J. S., Piao, Y. J., and Kang, K. W. (2011) Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin Arch. Pharm. Res. 34, 607-613
213. Frampton, G. A., Lazcano, E. A., Li, H., Mohamad, A., and DeMorrow, S. (2010) Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents Lab Invest. 90, 1325-1338
214. Zhou, M., Wang, S., Zhao, A., Wang, K., Fan, Z., Yang, H., Liao, W., Bao, S., Zhao, L., Zhang, Y., Yang, Y., Qiu, Y., Xie, G., Li, H., and Jia, W. (2012) Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice J. Proteome Res. 11, 4961-4971
215. Cohen, J. C., Cali, J. J., Jelinek, D. F., Mehrabian, M., Sparkes, R. S., Lusis, A. J., Russell, D. W., and Hobbs, H. H. (1992) Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12 Genomics 14, 153-161
216. Gåfvels, M., Olin, M., Chowdhary, B. P., Raudsepp, T., Andersson, U., Persson, B., Jansson, M., Björkhem, I., and Eggertsen, G. (1999) Structure and chromosomal assignment of the sterol 12alpha-hydroxylase gene (CYP8B1) in human and mouse: eukaryotic cytochrome P-450 gene devoid of introns Genomics 56, 184-196
217. Watanabe, M. and Ayugase, J. (2010) Effects of buckwheat sprouts on plasma and hepatic parameters in type 2 diabetic db/db mice J. Food Sci. 75, H294-299
218. Hoek-van den Hil, E. F., Keijer, J., Bunschoten, A., Vervoort, J. J., Stankova, B., Bekkenkamp, M., Herreman, L., Venema, D., Hollman, P. C., Tvrzicka, E., Rietjens, I. M., and van Schothorst, E. M. (2013) Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice PLoS One 8, e51588
219. Fowler, M. J. (2008) Microvascular and macrovascular complications of diabetes Clin. Diabetes 26, 77-82
220. Kusirisin, W., Jaikang, C., Chaiyasut, C., and Narongchai, P. (2009) Effect of polyphenolic compounds from Solanum torvum on plasma lipid peroxidation, superoxide anion and cytochrome P450 2E1 in human liver microsomes Med. Chem. 5, 583-588
221. Gandhi, G. R., Ignacimuthu, S., Paulraj, M. G., and Sasikumar, P. (2011) Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats Eur. J. Pharmacol. 670, 623-631
222. Gandhi, G. R., Ignacimuthu, S., and Paulraj, M. G. (2011) Solanum torvum Swartz. fruit containing phenolic compounds shows antidiabetic and antioxidant effects in streptozotocin induced diabetic rats Food Chem. Toxicol. 49, 2725-2733
223. Chaudhary, A. and Willett, K. L. (2006) Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort Toxicology 217, 194-205
224. Chang, T. K., Chen, J., and Yeung, E. Y. (2006) Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1 Toxicol. Appl. Pharmacol. 213, 18-26
225. Doostdar, H., Burke, M. D., and Mayer, R. T. (2000) Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1 Toxicology 144, 31-38
226. Chun, Y. J., Kim, S., Kim, D., Lee, S. K., and Guengerich, F. P. (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis Cancer Res. 61, 8164-8170